LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 1235 | 3879 | 4356 | 0.8904 | 0.8763 |
MCF7 | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 1235 | 4162 | 4326 | 0.9620 | 0.9576 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 1235 | 4423 | 4119 | 1.0737 | 1.0836 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 1235 | 4239 | 4356 | 0.9731 | 0.9702 |
MCF7 | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 1235 | 4395 | 4326 | 1.0158 | 1.0175 |
MCF7 | Enzastaurin | 1.11 | uM | LJP5 | 1 | D15 | 72 | hr | 1235 | 4196 | 4119 | 1.0186 | 1.0214 |
MCF7 | Enzastaurin | 1.11 | uM | LJP5 | 2 | D15 | 72 | hr | 1235 | 3514 | 4356 | 0.8067 | 0.7771 |
MCF7 | Enzastaurin | 1.11 | uM | LJP5 | 3 | D15 | 72 | hr | 1235 | 4084 | 4326 | 0.9440 | 0.9372 |
MCF7 | Enzastaurin | 3.33 | uM | LJP5 | 1 | D14 | 72 | hr | 1235 | 4008 | 4119 | 0.9730 | 0.9687 |
MCF7 | Enzastaurin | 3.33 | uM | LJP5 | 2 | D14 | 72 | hr | 1235 | 3560 | 4356 | 0.8172 | 0.7898 |
MCF7 | Enzastaurin | 3.33 | uM | LJP5 | 3 | D14 | 72 | hr | 1235 | 3635 | 4326 | 0.8402 | 0.8164 |
MCF7 | Enzastaurin | 10 | uM | LJP5 | 1 | D13 | 72 | hr | 1235 | 2356 | 4119 | 0.5720 | 0.4500 |
MCF7 | Enzastaurin | 10 | uM | LJP5 | 2 | D13 | 72 | hr | 1235 | 2309 | 4356 | 0.5300 | 0.4106 |
MCF7 | Enzastaurin | 10 | uM | LJP5 | 3 | D13 | 72 | hr | 1235 | 2272 | 4326 | 0.5251 | 0.4007 |
MCF7 | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 1235 | 2819 | 3974 | 0.7093 | 0.6314 |
MCF7 | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 1235 | 2950 | 4070 | 0.7248 | 0.6587 |
MCF7 | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 1235 | 3286 | 4126 | 0.7963 | 0.7546 |
MCF7 | Palbociclib | 0.12 | uM | LJP6 | 1 | E17 | 72 | hr | 1235 | 2263 | 3974 | 0.5694 | 0.4320 |
MCF7 | Palbociclib | 0.12 | uM | LJP6 | 2 | E17 | 72 | hr | 1235 | 2381 | 4070 | 0.5850 | 0.4644 |
MCF7 | Palbociclib | 0.12 | uM | LJP6 | 3 | E17 | 72 | hr | 1235 | 2632 | 4126 | 0.6379 | 0.5445 |
MCF7 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 1235 | 1899 | 3974 | 0.4778 | 0.2905 |
MCF7 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 1235 | 2338 | 4070 | 0.5744 | 0.4490 |
MCF7 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 1235 | 2135 | 4126 | 0.5174 | 0.3695 |
MCF7 | Palbociclib | 1.11 | uM | LJP6 | 1 | E15 | 72 | hr | 1235 | 1787 | 3974 | 0.4497 | 0.2448 |
MCF7 | Palbociclib | 1.11 | uM | LJP6 | 2 | E15 | 72 | hr | 1235 | 1757 | 4070 | 0.4317 | 0.2272 |